当前位置: X-MOL 学术J. Exp. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program
Journal of Experimental Medicine ( IF 12.6 ) Pub Date : 2017-10-02 , DOI: 10.1084/jem.20161827
Stephen J. Loughran 1, 2 , Federico Comoglio 1, 2 , Fiona K. Hamey 1, 2 , Alice Giustacchini 3 , Youssef Errami 1, 2 , Eleanor Earp 1, 2 , Berthold Göttgens 1, 2 , Sten Eirik W. Jacobsen 3, 4 , Adam J. Mead 3 , Brian Hendrich 2, 5 , Anthony R. Green 1, 2
Affiliation  

Differentiation of lineage-committed cells from multipotent progenitors requires the establishment of accessible chromatin at lineage-specific transcriptional enhancers and promoters, which is mediated by pioneer transcription factors that recruit activating chromatin remodeling complexes. Here we show that the Mbd3/nucleosome remodeling and deacetylation (NuRD) chromatin remodeling complex opposes this transcriptional pioneering during B cell programming of multipotent lymphoid progenitors by restricting chromatin accessibility at B cell enhancers and promoters. Mbd3/NuRD-deficient lymphoid progenitors therefore prematurely activate a B cell transcriptional program and are biased toward overproduction of pro–B cells at the expense of T cell progenitors. The striking reduction in early thymic T cell progenitors results in compensatory hyperproliferation of immature thymocytes and development of T cell lymphoma. Our results reveal that Mbd3/NuRD can regulate multilineage differentiation by constraining the activation of dormant lineage-specific enhancers and promoters. In this way, Mbd3/NuRD protects the multipotency of lymphoid progenitors, preventing B cell–programming transcription factors from prematurely enacting lineage commitment. Mbd3/NuRD therefore controls the fate of lymphoid progenitors, ensuring appropriate production of lineage-committed progeny and suppressing tumor formation.



中文翻译:

Mbd3 / NuRD通过抑制B细胞转录程序来控制淋巴样细胞命运并抑制肿瘤发生

从多能祖细胞分化出谱系定型细胞需要在谱系特异性转录增强子和启动子处建立可及的染色质,这是由募集活化染色质重塑复合物的先驱转录因子介导的。在这里,我们显示Mbd3 /核小体重塑和脱乙酰化(NuRD)染色质重塑复合物通过限制B细胞增强子和启动子在染色质上的可及性,反对多能性淋巴祖细胞B细胞编程过程中的这种转录先驱。因此,Mbd3 / NuRD缺陷型淋巴样祖细胞会过早激活B细胞转录程序,并偏向于Pro-B细胞过度生产,而以T细胞祖细胞为代价。早期胸腺T细胞祖细胞的显着减少导致未成熟胸腺细胞的代偿性过度增殖和T细胞淋巴瘤的发展。我们的结果表明,Mbd3 / NuRD可以通过限制休眠谱系特异性增强子和启动子的激活来调节多谱系分化。通过这种方式,Mbd3 / NuRD保护淋巴样祖细胞的多能性,防止B细胞编程转录因子过早发挥谱系作用。因此,Mbd3 / NuRD控制着淋巴样祖细胞的命运,确保适当产生谱系组成的后代并抑制肿瘤形成。我们的结果表明,Mbd3 / NuRD可以通过限制休眠谱系特异性增强子和启动子的激活来调节多谱系分化。通过这种方式,Mbd3 / NuRD保护淋巴样祖细胞的多能性,防止B细胞编程转录因子过早发挥谱系作用。因此,Mbd3 / NuRD控制着淋巴样祖细胞的命运,确保适当产生谱系组成的后代并抑制肿瘤形成。我们的结果表明,Mbd3 / NuRD可以通过限制休眠谱系特异性增强子和启动子的激活来调节多谱系分化。通过这种方式,Mbd3 / NuRD保护淋巴样祖细胞的多能性,防止B细胞编程转录因子过早发挥谱系作用。因此,Mbd3 / NuRD控制着淋巴样祖细胞的命运,确保适当产生谱系承诺的子代并抑制肿瘤形成。

更新日期:2017-10-02
down
wechat
bug